Interleukin‐17 is a potential player and treatment target in severe chronic spontaneous urticaria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukin‐17 is a potential player and treatment target in severe chronic spontaneous urticaria

Published:2020-06-29 Issue:7 Volume:50 Page:799-804
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Sabag D. A.¹,Matanes L.¹,Bejar J.²,Sheffer H.²,Barzilai A.³,Church M. K.⁴,Toubi E.¹,Maurer M.⁴^ORCID,Vadasz Z.¹^ORCID

Affiliation:

1. The Unit of Proteomics and Flow CytometryDivision of Allergy and Clinical ImmunologyTechnion Haifa Israel

2. Department of Pathology‐Bnai‐Zion Medical CenterFaculty of MedicineTechnion Haifa Israel

3. Department of DermatologySheba Medical Center Tel‐Aviv Israel

4. Dermatological AllergologyAllergie‐Centrum‐CharitéDepartment of Dermatology & AllergyCharité ‐ Universitätsmedizin Berlin Berlin Germany

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.13616

Reference17 articles.

1. Autoimmune chronic spontaneous urticaria: What we know and what we do not know

2. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis

3. Ligelizumab for Chronic Spontaneous Urticaria

4. Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria

5. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome;Clinical, Cosmetic and Investigational Dermatology;2024-08

2. Emerging Therapeutics in Chronic Urticaria;Immunology and Allergy Clinics of North America;2024-08

3. Strategien bei chronischer spontaner Urtikaria;HNO Nachrichten;2024-08

4. Disease modification in chronic spontaneous urticaria;Allergy;2024-07-24

5. CD4+CCR5+ T cells and CCL3+ mast cells are increased in the skin of patients with chronic spontaneous urticaria;Frontiers in Immunology;2024-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3